Insulet Corporation (PODD) support and resistance · P/E 34, rev $2.07B
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
This page maps Insulet Corporation (PODD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PODD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PODD quote page for the session range and the stock page for the full model.
Not investment advice.